Myxomatous Mitral Valve Disease in Senior Dogs

Understanding MMVD diagnosis, staging, and management strategies for aging dogs with the most common heart condition.

By SeniorPetCare Research Veterinary Health Research Team | Board-Certified Veterinary Specialists & Certified Animal Nutritionists | 20+ years combined clinical experience in geriatric pet medicine Published: May 19, 2026 Last updated: September 1, 2026

Quick Answer

Myxomatous Mitral Valve Disease (MMVD) is a common degenerative heart condition in senior dogs, especially small breeds over 7 years old. It causes the mitral valve to leak, leading to potential heart failure. Regular vet check-ups with a focus on heart murmurs are crucial for early diagnosis and management.

Article Summary — Key Takeaways

Reading time: 5 minutes | 6 key points

Point 1: MMVD affects 75% of dogs, especially small breeds over 7 years old.
Point 2: Diagnose MMVD using echocardiography for accurate valve and chamber assessment.
Point 3: Manage MMVD with ACE inhibitors, diuretics, and pimobendan based on disease stage.
Point 4: Implement dietary sodium restriction and omega-3s to support cardiac health.
Point 5: Regular monitoring and medication adjustments are crucial for optimal outcomes.
Point 6: Many dogs with MMVD can live several years with appropriate management.

What is the most common heart disease in senior dogs?

The most common [heart disease](https://seniorpet.org/knowledge/cavalier-king-charles-spaniel-mitral-valve-disease "Heart Disease in Senior Pets") affecting senior dogs is Myxomatous [Mitral Valve Disease](https://seniorpet.org/knowledge/cavalier-king-charles-spaniel-mitral-valve-disease "Mitral Valve Disease Guide") (MMVD), a progressive degenerative condition of the heart's mitral valve, accounting for approximately 75% of all canine cardiac cases. This condition primarily affects small breed dogs over 7 years of age, such as [Cavalier King Charles](https://seniorpet.org/knowledge/breed/cavalier-king-charles-spaniel "Senior Cavalier King Charles Spaniel Health Guide") Spaniels, Dachshunds, and Poodles.

Key Statistics & Research Data

Myxomatous mitral valve disease (MMVD) affects 75% of dogs over 16 years, with Cavalier King Charles Spaniels showing 100% prevalence by age 10. The ACVIM Stage B2 criteria (LA/Ao ≥1.6, LVIDDN ≥1.7) identify dogs who benefit from [pimobendan](https://seniorpet.org/knowledge/pimobendan-vetmedin-heart-failure-guide "Pimobendan Heart Failure Guide") therapy (Source: Keene et al., JVIM, 2019; Borgarelli et al., JVIM, 2012).

[Diabetes](https://seniorpet.org/knowledge/[beagle](https://seniorpet.org/knowledge/breed/beagle "Senior Beagle Health Guide")-diabetes "Diabetes Management in Senior Pets") mellitus has a prevalence of 0.4-1.2% in dogs and 0.4-1.2% in cats. Diabetic remission occurs in 25-30% of cats with early insulin therapy and dietary management, but in fewer than 5% of dogs (Source: O'Neill et al., Veterinary Record, 2016; Roomp & Rand, JFMS, 2009).

[Hyperthyroidism](https://seniorpet.org/knowledge/[siamese](https://seniorpet.org/knowledge/breed/siamese "Senior Siamese Cat Health Guide")-cat-hyperthyroidism "Hyperthyroidism in Senior Cats") affects approximately 10% of cats over age 10. Radioiodine therapy (I-131) achieves euthyroidism in 95% of cats with a single treatment, compared to 85% for surgical thyroidectomy (Source: Peterson, JFMS, 2012; Mooney, Veterinary Clinics of North America, 2001).

Renal diets reduce uremic crises by 75% and double median survival time in cats with IRIS Stage 2-3 CKD (from 7 to 14 months). Phosphorus restriction is the single most impactful dietary modification (Source: Elliott et al., JVIM, 2000; Ross et al., JAVMA, 2006).

How does Myxomatous Mitral Valve Disease (MMVD) affect a dog's heart?

MMVD, also known as endocardiosis or chronic valvular heart disease, involves the gradual deterioration of the mitral valve, preventing it from sealing properly. This malfunction causes blood to leak backward into the left atrium during each heart contraction, leading to increased pressure and volume within the heart chambers and potentially progressing to heart failure.

What are the different stages of Myxomatous Mitral Valve Disease (MMVD) in dogs?

Veterinary cardiologists classify MMVD into distinct stages using the American College of Veterinary Internal Medicine (ACVIM) consensus guidelines, ranging from at-risk dogs with no heart changes to those with severe heart failure. These stages help veterinarians determine the appropriate monitoring and treatment protocols for affected dogs.

Here is a breakdown of the MMVD stages:

How is Myxomatous Mitral Valve Disease (MMVD) diagnosed in senior dogs?

Diagnosing MMVD typically involves a comprehensive approach combining a physical examination, advanced imaging, and specialized cardiac tests. Early and accurate diagnosis is crucial for initiating timely management and improving a senior dog's quality of life.

A veterinarian will often begin with a physical examination, listening for characteristic heart murmurs that indicate blood leakage through the mitral valve. Further diagnostic steps include electrocardiography (ECG) to assess heart rhythm, chest radiographs (X-rays) to evaluate heart size and lung fluid, and echocardiography. Echocardiography, an ultrasound of the heart, is considered the gold standard for directly visualizing valve function, measuring chamber sizes, and assessing blood flow. According to SeniorPetCare's veterinary team, routine screening for MMVD is highly recommended for small breed dogs over 7 years of age.

What are the treatment options for Myxomatous Mitral Valve Disease (MMVD) in senior dogs?

Treatment for MMVD is tailored to the dog's specific disease stage, focusing on managing symptoms, reducing the heart's workload, and improving cardiac function. Early-stage MMVD (Stage B1) may only require careful monitoring, while more advanced stages necessitate a multi-drug approach.

Common medications prescribed include ACE inhibitors (e.g., enalapril, lisinopril) to reduce blood pressure and cardiac workload, and diuretics (e.g., furosemide) to manage fluid accumulation in the lungs and body. For dogs with arrhythmias, beta-blockers or calcium channel blockers may be used. Pimobendan, a medication that improves heart contractility and reduces cardiac workload, is often introduced in Stage B2 and beyond, significantly improving survival times and quality of life in many countries.

What dietary changes can help a dog with Myxomatous Mitral Valve Disease (MMVD)?

Nutritional management plays a supportive role in managing MMVD, aiming to reduce fluid retention, maintain muscle mass, and support overall cardiovascular health. Dietary adjustments are often recommended in conjunction with medical therapies.

Key dietary recommendations include sodium restriction to minimize fluid buildup, which can alleviate the heart's workload. Adequate protein intake is vital to prevent muscle wasting, a common issue in advanced heart disease. Supplementation with omega-3 fatty acids (e.g., from fish oil) can help reduce inflammation and support cardiac function. Ensuring a balanced intake of minerals, particularly potassium and magnesium, is also important for heart health.

Are there surgical options for Myxomatous Mitral Valve Disease (MMVD) in dogs?

While medical management is the primary treatment for MMVD, surgical intervention, specifically mitral valve repair or replacement, is an emerging but highly specialized option. This complex procedure is not widely available and is typically reserved for a small number of carefully selected cases.

Surgical options are generally considered in advanced stages for dogs that are otherwise healthy and have a good prognosis for recovery from surgery. These procedures require highly specialized veterinary cardiac surgeons and facilities, making them less accessible than conventional medical treatments.

What is the prognosis for a senior dog diagnosed with Myxomatous Mitral Valve Disease (MMVD)?

The prognosis for senior dogs with MMVD varies significantly depending on the disease stage at diagnosis, the dog's response to medication, and the presence of any concurrent health conditions. With appropriate and consistent management, many dogs can live several comfortable years after diagnosis.

SeniorPetCare research indicates that dogs diagnosed in preclinical stages (B1 or B2) often have a better long-term outlook, especially if pimobendan is initiated at the appropriate time. Regular veterinary check-ups, diligent medication administration, and prompt adjustments to treatment plans are essential for optimizing outcomes and maintaining a good quality of life for dogs living with MMVD.

Sources mentioned in this guide

These references are extracted from the article’s published research and statistics sections.

Keene et al., JVIM, 2019; Borgarelli et al., JVIM, 2012
O'Neill et al., Veterinary Record, 2016; Roomp & Rand, JFMS, 2009
Peterson, JFMS, 2012; Mooney, Veterinary Clinics of North America, 2001
Elliott et al., JVIM, 2000; Ross et al., JAVMA, 2006

Frequently Asked Questions

What is Myxomatous Mitral Valve Disease (MMVD) in senior dogs?

MMVD is a common degenerative heart condition in senior dogs where the mitral valve progressively thickens and loses its ability to seal properly. This causes blood to leak backward into the heart, potentially leading to heart failure over time. It is particularly prevalent in small breed dogs over 7 years of age.

How is MMVD diagnosed in senior dogs?

Diagnosis of MMVD involves a physical examination, electrocardiography (ECG), chest X-rays, and echocardiography. Echocardiography is considered the gold standard for evaluating valve function and heart chamber size. Regular screening is crucial for early detection in senior dogs, especially small breeds.

What are the common signs of MMVD in senior dogs?

While early stages of MMVD may show no outward signs, clinical signs of heart failure include coughing, exercise intolerance, and difficulty breathing. If you notice these symptoms in your senior dog, consult your veterinarian promptly. Early detection can help manage the disease effectively.

Can MMVD be treated in senior dogs?

Treatment for MMVD varies depending on its stage. Early preclinical stages might only require monitoring, while more advanced stages involve medications to reduce the heart's workload and manage fluid accumulation. Common medications include ACE inhibitors and diuretics.

What should I do if my senior dog is at risk for MMVD?

If your senior dog, especially a small breed, is at risk for MMVD, schedule regular veterinary check-ups for early detection. Your veterinarian can perform screenings like listening for heart murmurs and recommend further diagnostic tests if needed. Early intervention can significantly improve your dog's quality of life.

Addison's Disease in Senior Dogs: The Great Imitator Explained — Addison's disease in senior dogs is an endocrine disorder where the adrenal glands don't produce enough steroid hormones like cortisol and aldosterone. This deficiency impacts stress response, metabolism, inflammation, and electrolyte balance, often leading to a wide range of non-specific symptoms.
Chronic Kidney Disease in Senior Cats: Early Detection and Management — Early detection of chronic kidney disease (CKD) in senior cats is crucial for managing this common, irreversible condition. Look for subtle signs like increased thirst and urination, weight loss, or decreased appetite. Regular veterinary check-ups, especially for cats over 7, including blood and urine tests, can identify CKD early, allowing for interventions that improve quality of life.
Common Cancers in Senior Dogs: Diagnosis and Management — Common cancers in senior dogs include lymphoma, hemangiosarcoma, and osteosarcoma. Early detection through regular vet check-ups and monitoring for signs like lumps, lethargy, or sudden collapse is crucial. Treatment options like chemotherapy and surgery can significantly extend a senior dog's quality of life.
Common Cancers in Senior Cats: Diagnosis and Management — Senior cats commonly develop lymphoma (30% of feline cancers) and oral squamous cell carcinoma. Watch for signs like weight loss, lethargy, difficulty eating, or enlarged lymph nodes. Early diagnosis and treatment, often involving chemotherapy for lymphoma, can significantly improve your cat's prognosis and quality of life.
Feline Hypertrophic Cardiomyopathy: Diagnosis and Management — Feline hypertrophic cardiomyopathy (HCM) in senior cats is diagnosed primarily through echocardiography, which measures heart wall thickness. While many cats are asymptomatic, watch for lethargy, rapid breathing, and decreased appetite. Early detection is crucial for managing this common heart disease.
Dilated Cardiomyopathy in Senior Dogs: Understanding and Managing DCM — Dilated cardiomyopathy (DCM) in senior dogs is a serious heart condition where the heart enlarges and weakens, reducing its pumping ability. While often silent initially, watch for lethargy, coughing, or difficulty breathing, especially in large breeds. Early diagnosis through veterinary exams and tests is crucial for managing the disease and improving your dog's quality of life.